Loading clinical trials...
Loading clinical trials...
Metabolic Mechanisms Induced by Enteral Docosahexaenoic Acid (DHA) and Arachidonic Acid (ARA) Supplementation in Preterm Infants
Conditions
Interventions
Enfamil® DHA & ARA Supplement for Special Dietary Use
Locations
7
United States
University of California, Los Angeles (UCLA)
Los Angeles, California, United States
Yale New Haven Hospital
New Haven, Connecticut, United States
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
Northwestern University
Chicago, Illinois, United States
Weill Cornell Medicine
New York, New York, United States
University Health System
San Antonio, Texas, United States
Start Date
March 9, 2023
Primary Completion Date
April 1, 2027
Completion Date
April 1, 2028
Last Updated
September 24, 2025
NCT07434271
NCT07410858
NCT07371845
NCT07216664
NCT07322731
NCT06335524
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions